Stay updated on Opregen in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated to include new dates in April 2025 and a revision update to version 2.15.2, while previous dates and the older revision version 2.15.0 have been removed.
    Difference
    1%
    Check dated 2025-05-01T06:14:33.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding a clinical trial for OpRegen in patients with geographic atrophy, while a new version number has been added.
    Difference
    19%
    Check dated 2025-04-16T20:25:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T13:19:55.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has updated the criteria for participant eligibility in a clinical study, specifically changing the BCVA score requirement and the date associated with the study.
    Difference
    1%
    Check dated 2025-04-02T00:05:50.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The webpage has updated its date listings, adding several future dates while removing others. Notably, the previous notices regarding service performance and contact information have been removed.
    Difference
    4%
    Check dated 2025-02-24T23:08:21.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T16:44:24.000Z thumbnail image

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.